Cleared Traditional

AI4CMR v1.0 (K220624) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2022
Decision
141d
Days
Class 2
Risk

K220624 is an FDA 510(k) clearance for the AI4CMR v1.0. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Ai4medimaging Medical Solutions S.A. (Braga, PT). The FDA issued a Cleared decision on July 22, 2022 after a review of 141 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Ai4medimaging Medical Solutions S.A. devices

Submission Details

510(k) Number K220624 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 03, 2022
Decision Date July 22, 2022
Days to Decision 141 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
34d slower than avg
Panel avg: 107d · This submission: 141d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 797
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K220624.
Dolphin Imaging 12.0
K222072 · Patterson Dental Supply, Inc. · Aug 2022
Neurophet SCALE PET
K221405 · Neurophet., Inc. · Aug 2022
FX SPS
K213922 · Pixee Medical · Jul 2022
AutoSeg
K220039 · Ai Medic, Inc. · Jul 2022
Functional MR V1.0
K221426 · Olea Medical S.A.S. · Jul 2022
Axial3D Cloud Segmentation Service
K221511 · Axial Medical Printing Limited · Jun 2022